Volume 45 Issue 4
Apr.  2024
Turn off MathJax
Article Contents
Abstract
References
Relative Articles
Article Navigation >  Journal of Kunming Medical University  > 2024  >  45(4): 163-169
Xin WU, Yun LI, Pin-fei ZOU, Mei-ling LI, Yong-bin PU. The Detection Rate of Musculoskeletal Ultrasound in Patients with Rheumatic Knee Arthritis and Its Correlation with Knee Function[J]. Journal of Kunming Medical University, 2021, 42(8): 78-82. doi: 10.12259/j.issn.2095-610X.S20210814
Citation: Ying WANG, Cong FU, Ying FU. Clinical Implications of Serum LDH，CysC，and PWR Level Detection in Lung Cancer Patients[J]. Journal of Kunming Medical University, 2024, 45(4): 163-169. doi: 10.12259/j.issn.2095-610X.S20240424
shu

Clinical Implications of Serum LDH，CysC，and PWR Level Detection in Lung Cancer Patients

doi: 10.12259/j.issn.2095-610X.S20240424

  • Dept. of Medical Record Statistics，The 4th People’s Hospital of Changzhou City，Changzhou Jiangsu 213000，China

  • Received Date: 2023-12-28
  • Publish Date: 2024-04-25
    Abstract
  •   Objective   To investigate the clinical implications of lung function index, serum lactate dehydrogenase（LDH）, cysteine protease inhibitor C（CysC） and platelet/white blood cell ratio（PWR） in patients with lung cancer.   Methods   From January 2023 to June 2023, 72 patients with lung cancer in the Fourth People's Hospital of Changzhou were selected as the observation group, and 72 patients with benign lung diseases during the same period were selected as the control group. LDH, CysC, PWR and tumor markers [carcinoembryonic antigen（CEA）, neuron-specific enolase（NSE）, cytokeratin fragment 19（CYFRA21-1）] were compared between the two groups, and the correlation between LDH, PWR, CysC and tumor markers was analyzed. The levels of LDH, CysC and PWR in patients with lung cancer with different pathological characteristics were compared, and the correlation between the levels of LDH, PWR, CysC and pathological characteristics in patients with lung cancer was analyzed. The diagnostic value of LDH, CysC, PWR combined with CEA, CYFRA21-1 and NSE in lung cancer was evaluated.   Results   The PWR of the observation group was lower than that of the control group, and the LDH, CysC, CEA, CYFRA21-1 and NSE were higher than those of the control group（P < 0.05）. PWR was negatively correlated with tumor markers CEA, CYFRA21-1 and NSE（ P < 0.05）, LDH and CysC were positively correlated with tumor markers CEA, CYFRA21-1 and NSE（ P < 0.05）. There was no significant difference in LDH, CysC and PWR between lung adenocarcinoma and lung squamous cell carcinoma（ P > 0.05）. In terms of clinical stage, PWR of stage Ⅰ- Ⅱ patients was higher than that of stage Ⅲ-Ⅳ patients, LDH and CysC were lower than those of stage Ⅲ-Ⅳ patients（ P < 0.05）. In terms of lymph node metastasis, the PWR of patients without lymph node metastasis was higher than that of patients with lymph node metastasis, and LDH and CysC were lower than those of patients with lymph node metastasis（ P < 0.05）. LDH, PWR and CysC in lung cancer patients were not correlated with pathological type（ P > 0.05）, PWR was negatively correlated with clinical stage and lymph node metastasis（ P < 0.05）, LDH and CysC were positively correlated with clinical stage and lymph node metastasis（ P < 0.05）. The ROC curve showed that the area under the curve（AUC） value of the combination of LDH, CysC and PWR in the diagnosis of lung cancer was 0.910, and the AUC value of the combination of CEA, CYFRA21-1 and NSE was 0.923. Further use of LDH, CysC, PWR combined with CEA, CYFRA21-1, NSE diagnostic AUC value was the highest, 0.940, the sensitivity and specificity were 93.06% and 87.33%, respectively.   Conclusion   The PWR of lung cancer patients is decreased, and the levels of LDH and CysC are increased, and their levels are closely related to tumor markers, clinical stage and lymph node metastasis, which can assist tumor markers in the diagnosis of lung cancer, in order to improve the diagnosis rate of early lung cancer.
    • FullText(HTML)
    • References(23)
  • [1]
    Thai A A,Solomon B J,Sequist L V,et al. Lung cancer[J]. Lancet,2021,398(10299):535-554. doi: 10.1016/S0140-6736(21)00312-3
    [2]
    Nooreldeen R,Bach H. Current and future development in lung cancer diagnosis[J]. Int J Mol Sci,2021,22(16):8661. doi: 10.3390/ijms22168661
    [3]
    Oliver A L. Lung cancer: Epidemiology and screening[J]. Surg Clin North Am,2022,102(3):335-344. doi: 10.1016/j.suc.2021.12.001
    [4]
    夏进,陈培,官和立,等. 早期肺癌筛查人群患病风险队列研究[J]. 现代预防医学,2023,50(12):2284-2288.
    [5]
    胡明明,阳苑,张同梅,等. 7843例原发肺恶性肿瘤流行病学特征分析[J]. 现代肿瘤医学,2021,29(4):682-685. doi: 10.3969/j.issn.1672-4992.2021.04.031
    [6]
    Liam C K,Lee P,Yu CJ,et al. The diagnosis of lung cancer in the era of interventional pulmonology[J]. Int J Tuberc Lung Dis,2021,25(1):6-15. doi: 10.5588/ijtld.20.0588
    [7]
    支修益,石远凯,于金明. 中国原发性肺癌诊疗规范(2015年版)[J]. 中华肿瘤杂志,2015,37(1):67-78. doi: 10.3760/cma.j.issn.0253-3766.2015.01.014
    [8]
    王敏,王媛,孙静,等. 人参养荣汤对Lewis肺癌糖酵解途径相关酶LDH-A、HK2基因表达的影响[J]. 辽宁中医杂志,2022,49(1):180-184.
    [9]
    刘浩,刘文,向辉,等. 半胱氨酸蛋白酶抑制剂C对胃癌侵袭与转移的影响[J]. 吉林医学,2022,43(12):3194-3197. doi: 10.3969/j.issn.1004-0412.2022.12.007
    [10]
    李白坤,朱继民,李庆林. 血小板与白细胞相互作用介导的肿瘤炎症微环境及其中医药治疗策略[J]. 安徽中医药大学学报,2021,40(1):93-96. doi: 10.3969/j.issn.2095-7246.2021.01.023
    [11]
    An J,Gu Q H,Cao L M,et al. Serum IL-6 as a vital predictor of severe lung cancer[J]. Ann Palliat Med,2021,10(1):202-209. doi: 10.21037/apm-20-2229
    [12]
    Yu J Q,Du F,Yang LP,et al. Identification of potential serum biomarkers for simultaneously classifying lung adenocarcinoma,squamous cell carcinoma and small cell carcinoma[J]. Cancer Biomark,2021,30(3):331-342. doi: 10.3233/CBM-201440
    [13]
    Xu C H,Li L,Wang W,et al. Serum macrophage inhibitory cytokine-1 as a clinical marker for non-small cell lung cancer[J]. J Cell Mol Med,2021,25(6):3169-3172. doi: 10.1111/jcmm.16360
    [14]
    Kerr K M,Bibeau F,Thunnissen E,et al. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe[J]. Lung Cancer,2021,154(11):161-175.
    [15]
    齐艳春,陈玲玲,全勍,等. ProGRP、CEA、NSE、CYFRA21-1、CA125、SCC对不同病理类型肺癌的诊断价值及联合检测的临床意义[J]. 牡丹江医学院学报,2023,44(3):62-66.
    [16]
    王妮娜,李晓花,陈敏丽,等. 肺癌患者血清NSE,SCC,CA125及CYFRA21-1水平检测在不同病理类型早期诊断和化疗疗效评价中的应用价值[J]. 现代检验医学杂志,2021,36(1):33-37. doi: 10.3969/j.issn.1671-7414.2021.01.009
    [17]
    陈礼昌,滕凤猛. 血清肿瘤标志物在肺癌不同病理分型中的应用价值[J]. 临床误诊误治,2022,35(1):29-32,47. doi: 10.3969/j.issn.1002-3429.2022.01.008
    [18]
    Qiu X,Shi Z,Tong F,et al. Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer[J]. Hum Vaccin Immunother,2023,19(1):2178791. doi: 10.1080/21645515.2023.2178791
    [19]
    Lahoud R M,O'Shea A,El-Mouhayyar C,et al. Tumour markers and their utility in imaging of abdominal and pelvic malignancies[J]. Clin Radiol,2021,76(2):99-107. doi: 10.1016/j.crad.2020.07.033
    [20]
    王云,牛华,方浩徽. C反应蛋白/清蛋白比率乳酸脱氢酶预测非小细胞肺癌患者预后的应用价值[J]. 安徽医学,2022,43(8):912-917. doi: 10.3969/j.issn.1000-0399.2022.08.009
    [21]
    李冰. 恶性肿瘤血清同型半胱氨酸和胱抑素C检测的临床价值探讨[J]. 中国疗养医学,2015,24(11):1188-1189.
    [22]
    Winther-Larsen A,Aggerholm-Pedersen N,Sandfeld-Paulsen B. Inflammation scores as prognostic biomarkers in small cell lung cancer: A systematic review and meta-analysis[J]. Syst Rev,2021,10(1):40. doi: 10.1186/s13643-021-01585-w
    [23]
    高心怡,陈丽,甘建和. MELD评分联合血小板/白细胞比值对HBV相关慢加急性肝衰竭患者预后的预测价值[J]. 临床肝胆病杂志,2021,37(5):1070-1074. doi: 10.3969/j.issn.1001-5256.2021.05.019
    • Relative Articles(20)

  • Relative Articles

    [1] Yang LI, Rong LIU, Chaomin LIU, Longyu XU, Wenjing ZHANG. Bioinformatics-based Identification of Cuproptosis Genes Associated with Prognosis and Immune Microenvironment in Lung Cancer. Journal of Kunming Medical University, 2025, 46(): 1-7.
    [2] Qianrong YANG, Xue CAO, Jiao YANG, Yanqiu ZHAO, Nan SHEN, Yajiao SUN. Status and Influencing Factors of Stigma in Lung Cancer Patients. Journal of Kunming Medical University, 2025, 46(1): 60-67.  doi: 10.12259/j.issn.2095-610X.S20250108
    [3] Jiang ZHANG, Xijuan ZHAO, Jiang WU, Bingkun YANG, Ni YANG, Liping ZHOU. Analysis of Frailty Status and Influencing Factors in Lung Cancer Patients Undergoing Radiotherapy. Journal of Kunming Medical University, 2025, 46(2): 126-133.  doi: 10.12259/j.issn.2095-610X.S20250218
    [4] Ruicheng LI, Hongwei QIAN, Yanni FAN, Peipei ZHAO, Shan WEI, Huarong JING. Application of Logistic Regression and Artificial Neural Networks in the Differential Diagnosis of LC-MPE. Journal of Kunming Medical University, 2024, 45(10): 55-60.  doi: 10.12259/j.issn.2095-610X.S20241009
    [5] Qun HUANG, Lili HOU, Degui WANG, Zhaojun WANG, Siyuan WU, Yingying SANG. The Effect of Active Circulatory Breathing Training in Patients undergoing Lung Cancer Surgery under 5A Mode. Journal of Kunming Medical University, 2024, 45(6): 190-196.  doi: 10.12259/j.issn.2095-610X.S20240627
    [6] Hongbo ZHANG, Zhenlong LI, Ying LV, Yichao ZHANG, Xiangming QIU, Tingting HUANG. Comparison of Clinical Efficacy of Single-port and Double-port Video-assisted Thoracoscopic Lobectomy in the Treatment of Lung Cancer. Journal of Kunming Medical University, 2024, 45(4): 135-139.  doi: 10.12259/j.issn.2095-610X.S20240419
    [7] Yajie SAI, Lvxin YAO, Ling CHENG, Li SHEN, Cailian QI, Zhaoxia WANG, Huatao NIU. Correlation Analysis between the Caregiver Burden and Life Meaning in Patients with the Early Diagnosis of Lung Cancer. Journal of Kunming Medical University, 2023, 44(9): 171-175.  doi: 10.12259/j.issn.2095-610X.S20230906
    [8] Teng-fei ZHANG, Yue-feng HE, Lei ZHANG, Li ZHANG, Kai-yun YANG, Lian-qing LIU, Hui TAN. Expression of Long Non-coding RNA APTR，HEIH，FAS-ASA1，FAM83H-AS1，DICER1-AS1，PR-lncRNA in Lung Cancer. Journal of Kunming Medical University, 2021, 42(4): 49-52.  doi: 10.12259/j.issn.2095-610X.S20210409
    [9] Jiang ZHANG, Xi-juan ZHAO, Jiang WU, Yan LIU, Li-juan LI, Ye CHEN. Application of Family Empowerment Nursing Intervention Program in Patients with Lung Cancer Undergoing Radiotherapy. Journal of Kunming Medical University, 2021, 42(12): 169-176.  doi: 10.12259/j.issn.2095-610X.S20211242
    [10] Chang LIU, Zhen-hua LI, Ying WANG, Yan-qin RUAN, Lai-hao QU, Ding-biao LI. Applications of Lung Cancer MDT Combined with PBL + CBL Model in the Clinical Teaching. Journal of Kunming Medical University, 2021, 42(9): 162-166.  doi: 10.12259/j.issn.2095-610X.S20210911
    [11] Ming-jie NING, Ying CHEN. Research Progress of The Correlation between Lung Microbiome and Lung Cancer. Journal of Kunming Medical University, 2021, 42(3): 155-160.  doi: 10.12259/j.issn.2095-610X.S20210336
    [12] Zhao Min , Bi Jun Qiang , Zhou Yong Chun , Zhang Jin Ping , Luo Lei . Characteristics and Trends of Disease Constitution of 9553 Inpatients with Lung Cancer in Yunnan Province. Journal of Kunming Medical University, 2017, 38(04): 63-67.
    [13] Fan Min Juan , Zhong Yun Hua , Shen Wen , Yuan Kai Fen , Zhao Guo Hou , Wang Shu Kun , Wen Lin Qiao . HSF2 Promotes Heat Shock Protein Expression in Lung Cancer. Journal of Kunming Medical University, 2017, 38(06): 108-112.
    [14] Zhao Jie . The Expression and Significance of Galectin-3 in COPD and Lung Cancer. Journal of Kunming Medical University,
    [15] Wang Hong . Role of Prostaglandin E2 in the Pathogenesis of COPD with Lung Cancer. Journal of Kunming Medical University,
    [16] Liu Yu . The Value of Renal Tubular Injury Biomarkers in Diagnosis of Primary Nephrotic Syndrome. Journal of Kunming Medical University,
    [17] He Xiao Yu . . Journal of Kunming Medical University,
    [18] Pan Long Fang . . Journal of Kunming Medical University,
    [19] Ma Jian Qiang . . Journal of Kunming Medical University,
    [20] Chen Jin Run . . Journal of Kunming Medical University,
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(12)

    1. 万珍珍，韩巧，卢晓春，苗国蓉，林兴洁，张小霞. 类风湿性关节炎肌骨超声影像特征在临床疗效评估中的应用. 影像研究与医学应用. 2024(01): 84-86 .
    2. 宋鑫，陈晓佳，邢宇飞. 肌骨超声在膝关节骨性关节炎诊断中的应用及同Lysholm评分的相关性分析. 黑龙江医学. 2024(07): 823-825 .
    3. 孙艳翠. 基于肌骨超声评价膝骨关节炎患者股直肌超声形态及与膝关节功能的相关性. 影像研究与医学应用. 2024(07): 69-71 .
    4. 李娜娜，李金勇，张丽平. 高频肌骨超声诊断踝关节外侧副韧带损伤的价值. 社区医学杂志. 2024(15): 513-518 .
    5. 张金花，俞晋虹. 肌骨超声检查在急性痛风性关节炎诊断及病情评估中的价值. 中国医疗器械信息. 2023(10): 117-119 .
    6. 朱红燕，陈晁，易建红. 肌骨超声对膝关节滑膜炎患者的诊断价值研究. 影像研究与医学应用. 2023(15): 135-137 .
    7. 金敏. 肌骨超声检查对风湿性膝关节炎的检出率及与膝关节功能的相关性. 现代医用影像学. 2023(12): 2363-2365 .
    8. 齐建文. 肌肉骨骼超声联合超声弹性成像参数对膝骨关节炎患者膝关节功能的评估价值研究. 现代诊断与治疗. 2023(18): 2815-2817 .
    9. 姜珊，李静，陈洁，陶腊梅，陆瑾，谢志红. 肌骨超声在针灸临床疗效评估中的应用进展. 世界科学技术-中医药现代化. 2023(12): 4047-4051 .
    10. 董静，尹春琼，陈关芬，倪樱祝. 肌骨超声对类风湿关节炎患者的诊断价值分析. 影像研究与医学应用. 2022(06): 55-57 .
    11. 刘丽. 退行性膝骨性关节炎患者分别行MSCT及MRI扫描的结果及影像学特征对比研究. 影像研究与医学应用. 2022(17): 116-118 .
    12. 朱永涛，回瑾，郭玲，张丁丁，耿进朝，安立国，周显飞. 肌肉骨骼超声与MRI诊断类风湿性膝关节炎及评估其活动度的价值比较. 长春中医药大学学报. 2022(11): 1253-1257 .

    Other cited types(1)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04050100150200
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 36.4 %FULLTEXT: 36.4 %META: 63.0 %META: 63.0 %PDF: 0.6 %PDF: 0.6 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 3.4 %其他: 3.4 %其他: 0.0 %其他: 0.0 %China: 0.0 %China: 0.0 %Falkenstein: 0.3 %Falkenstein: 0.3 %Rochester: 0.0 %Rochester: 0.0 %上海: 4.9 %上海: 4.9 %东莞: 0.0 %东莞: 0.0 %丹东: 0.0 %丹东: 0.0 %九江: 0.1 %九江: 0.1 %佳木斯: 0.0 %佳木斯: 0.0 %保定: 0.0 %保定: 0.0 %六安: 0.1 %六安: 0.1 %北京: 45.3 %北京: 45.3 %十堰: 0.1 %十堰: 0.1 %南京: 0.5 %南京: 0.5 %南宁: 0.0 %南宁: 0.0 %南通: 0.1 %南通: 0.1 %博阿努瓦: 0.1 %博阿努瓦: 0.1 %周口: 0.1 %周口: 0.1 %呼和浩特: 0.0 %呼和浩特: 0.0 %和田: 0.0 %和田: 0.0 %咸阳: 0.1 %咸阳: 0.1 %哈尔滨: 0.0 %哈尔滨: 0.0 %唐山: 0.0 %唐山: 0.0 %嘉兴: 0.1 %嘉兴: 0.1 %天津: 0.6 %天津: 0.6 %太原: 0.0 %太原: 0.0 %常州: 0.0 %常州: 0.0 %广安: 0.1 %广安: 0.1 %广州: 0.1 %广州: 0.1 %廊坊: 0.0 %廊坊: 0.0 %延安: 0.1 %延安: 0.1 %张家口: 2.0 %张家口: 2.0 %成都: 0.0 %成都: 0.0 %扬州: 0.3 %扬州: 0.3 %承德: 0.0 %承德: 0.0 %揭阳: 0.1 %揭阳: 0.1 %无锡: 0.2 %无锡: 0.2 %昆明: 0.9 %昆明: 0.9 %晋城: 0.0 %晋城: 0.0 %景德镇: 0.0 %景德镇: 0.0 %曲靖: 0.0 %曲靖: 0.0 %杭州: 0.3 %杭州: 0.3 %枣庄: 0.0 %枣庄: 0.0 %梅州: 0.0 %梅州: 0.0 %武汉: 0.2 %武汉: 0.2 %沈阳: 0.2 %沈阳: 0.2 %洛阳: 0.2 %洛阳: 0.2 %海得拉巴: 0.0 %海得拉巴: 0.0 %淄博: 0.0 %淄博: 0.0 %淮北: 0.1 %淮北: 0.1 %深圳: 0.3 %深圳: 0.3 %温州: 0.2 %温州: 0.2 %湘潭: 0.0 %湘潭: 0.0 %漯河: 1.2 %漯河: 1.2 %玉溪: 0.1 %玉溪: 0.1 %百色: 0.0 %百色: 0.0 %眉山: 0.2 %眉山: 0.2 %石家庄: 0.6 %石家庄: 0.6 %秦皇岛: 0.0 %秦皇岛: 0.0 %绍兴: 0.0 %绍兴: 0.0 %绥化: 0.1 %绥化: 0.1 %芒廷维尤: 6.1 %芒廷维尤: 6.1 %芝加哥: 0.2 %芝加哥: 0.2 %苏州: 0.0 %苏州: 0.0 %蚌埠: 0.0 %蚌埠: 0.0 %衡阳: 0.0 %衡阳: 0.0 %襄阳: 0.0 %襄阳: 0.0 %西宁: 11.5 %西宁: 11.5 %西雅图: 0.1 %西雅图: 0.1 %诺沃克: 0.3 %诺沃克: 0.3 %运城: 0.1 %运城: 0.1 %连云港: 0.0 %连云港: 0.0 %邯郸: 0.1 %邯郸: 0.1 %郑州: 0.2 %郑州: 0.2 %重庆: 0.2 %重庆: 0.2 %银川: 0.1 %银川: 0.1 %长沙: 0.8 %长沙: 0.8 %青岛: 0.3 %青岛: 0.3 %驻马店: 14.2 %驻马店: 14.2 %齐齐哈尔: 0.3 %齐齐哈尔: 0.3 %其他其他ChinaFalkensteinRochester上海东莞丹东九江佳木斯保定六安北京十堰南京南宁南通博阿努瓦周口呼和浩特和田咸阳哈尔滨唐山嘉兴天津太原常州广安广州廊坊延安张家口成都扬州承德揭阳无锡昆明晋城景德镇曲靖杭州枣庄梅州武汉沈阳洛阳海得拉巴淄博淮北深圳温州湘潭漯河玉溪百色眉山石家庄秦皇岛绍兴绥化芒廷维尤芝加哥苏州蚌埠衡阳襄阳西宁西雅图诺沃克运城连云港邯郸郑州重庆银川长沙青岛驻马店齐齐哈尔

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(7)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (978) PDF downloads(11) Cited by(13)
    Proportional views
    Related

    Copyright © 《昆明医科大学学报》编辑部  滇ICP备00000000号-0

    Publishing: 昆明医科大学学报编辑部

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return